down arrow

Suven Pharma

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE03QK01018
  • NSEID: SUVENPHAR
  • BSEID: 543064
INR
1,120.85
68.65 (6.52%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 3.22 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Rs cr
Consolidate Annual Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Net Sales
1,051.35
1,340.33
1,320.22
1,009.72
833.79
377.83
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,051.35
1,340.33
1,320.22
1,009.72
833.79
377.83
Raw Material Cost
265.88
430.08
459.46
310.32
240.24
124.52
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
49.15
-20.94
-60.35
-8.37
-11.05
-21.32
Employee Cost
135.92
118.25
100.48
76.23
73.72
29.63
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
177.05
173.18
133.78
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
10.35
11.06
105.75
51.30
Other Expenses
194.59
61.72
57.67
46.21
40.02
22.15
Total Expenditure (Excl Depreciation)
645.54
766.16
740.79
569.23
448.68
206.28
Operating Profit (PBDIT) excl Other Income
405.81
574.17
579.43
440.49
385.11
171.55
Other Income
61.91
46.36
92.38
14.24
18.12
0.60
Operating Profit (PBDIT)
467.72
620.53
671.81
454.73
403.23
172.15
Interest
7.45
12.81
6.23
9.14
23.07
2.79
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
460.27
607.72
665.58
445.59
380.16
169.36
Depreciation
54.60
47.99
39.10
31.64
23.86
11.50
Profit Before Tax
405.67
559.73
626.48
413.93
356.30
157.87
Tax
105.39
148.44
213.78
105.33
87.51
48.59
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
300.28
411.29
412.69
308.60
268.79
109.27
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
300.28
411.29
412.69
308.60
268.79
109.27
Share in Profit of Associates
0.00
0.00
41.11
53.74
48.21
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
300.28
411.29
453.80
362.34
317.00
109.27
Equity Capital
25.46
25.46
25.46
25.46
12.73
12.73
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
2,025.21
1,709.73
1,501.72
1,155.35
832.03
577.56
Earnings per share (EPS)
11.79
16.15
17.82
14.23
24.9
8.58
Diluted Earnings per share
11.8
16.16
17.83
14.23
24.91
8.59
Operating Profit Margin (Excl OI)
38.6%
42.84%
43.89%
43.62%
46.19%
45.4%
Gross Profit Margin
43.78%
45.34%
50.41%
44.13%
45.59%
44.82%
PAT Margin
28.56%
30.69%
34.37%
35.89%
38.02%
28.92%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2024 is -21.56% vs 1.52% in Mar 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Mar 2024 is -26.99% vs -9.37% in Mar 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2024 is -29.32% vs -0.91% in Mar 2023

stock-summary

Interest

YoY Growth in year ended Mar 2024 is -41.84% vs 105.62% in Mar 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2024 has fallen from Mar 2023

Compare Annual Results Of Suven Pharma With
Markets Mojo
Figures in Rs cr
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
1,051.35
10,334.77
-9,283.42
-89.83%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,051.35
10,334.77
-9,283.42
-89.83%
Raw Material Cost
265.88
1,853.52
-1,587.64
-85.66%
Purchase of Finished goods
0.00
1,409.85
-1,409.85
-100.00%
(Increase) / Decrease In Stocks
49.15
-53.67
102.82
191.58%
Employee Cost
135.92
2,274.73
-2,138.81
-94.02%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
194.59
2,315.28
-2,120.69
-91.60%
Total Expenditure (Excl Depreciation)
645.54
7,799.71
-7,154.17
-91.72%
Operating Profit (PBDIT) excl Other Income
405.81
2,535.06
-2,129.25
-83.99%
Other Income
61.91
280.86
-218.95
-77.96%
Operating Profit (PBDIT)
467.72
2,815.92
-2,348.20
-83.39%
Interest
7.45
33.53
-26.08
-77.78%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
460.27
2,782.39
-2,322.12
-83.46%
Depreciation
54.60
398.25
-343.65
-86.29%
Profit Before Tax
405.67
2,384.14
-1,978.47
-82.98%
Tax
105.39
457.58
-352.19
-76.97%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
300.28
1,926.56
-1,626.28
-84.41%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
300.28
1,926.56
-1,626.28
-84.41%
Share in Profit of Associates
0.00
15.21
-15.21
-100.00%
Minority Interest
0.00
-28.87
28.87
100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
300.28
1,912.90
-1,612.62
-84.30%
Equity Capital
25.46
40.06
-14.60
-36.45%
Face Value
1.00
1.00
0.00
Reserves
2,025.21
9,323.03
-7,297.82
-78.28%
Earnings per share (EPS)
11.79
47.75
-35.96
-75.31%
Diluted Earnings per share
11.80
47.68
-35.88
-75.25%
Operating Profit Margin (Excl OI)
38.60%
24.53%
0.00
14.07%
Gross Profit Margin
43.78%
26.92%
0.00
16.86%
PAT Margin
28.56%
18.79%
0.00
9.77%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 1,051.35 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is -21.56% vs 1.52% in Mar 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 300.28 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is -26.99% vs -9.37% in Mar 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 405.81 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is -29.32% vs -0.91% in Mar 2023

Annual - Interest
Interest 7.45 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is -41.84% vs 105.62% in Mar 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 38.60%
in Mar 2024

Figures in Rs %
stock-summary

YoY Growth in year ended Mar 2024 has fallen from Mar 2023